Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stenting in acute myocardial infarction.

M C Morice1, T Lefèvre, Y Louvard

  • 1Institut Cardiovasculaire Paris Sud, Institut Hospitalier Jacques Cartier, Massy, France. morice-mc@lmn-tech.com

Seminars in Interventional Cardiology : SIIC
|April 23, 1999
PubMed
Summary

Coronary stenting effectively addresses limitations of angioplasty in acute myocardial infarction (MI). This registry study shows low rates of repeat MI (1%) and mortality (3.7%) with direct stenting in acute MI patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectroscopic limits of diamond anvils to 520 GPa and projected bandgap closure.

Nature communications·2026
Same author

Importance of preserving coronary branches during angioplasty, assessed by cardiac resonance.

BMJ case reports·2025
Same author

Filamentation of a relativistic proton bunch in plasma.

Physical review. E·2024
Same author

Hosing of a Long Relativistic Particle Bunch in Plasma.

Physical review letters·2024
Same author

FOCUS: fast Monte Carlo approach to coherence of undulator sources.

Journal of synchrotron radiation·2023
Same author

Controlled Growth of the Self-Modulation of a Relativistic Proton Bunch in Plasma.

Physical review letters·2022

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) has limitations in acute myocardial infarction (MI), including recurrent ischemia, restenosis, and reocclusion.
  • Coronary artery stenting has emerged as a promising solution to overcome these PTCA limitations.
  • Preliminary studies like Stent PAMI, STENTIM, and ZWOLLE trials indicate favorable outcomes with stenting.

Purpose of the Study:

  • To evaluate the efficacy and safety of direct angioplasty and stenting in the acute phase of myocardial infarction.
  • To assess the rates of repeat myocardial infarction and mortality in patients treated with this strategy.

Main Methods:

  • Analysis of the ICPS registry data.
  • Inclusion of 519 patients directly treated with angioplasty and stenting during acute myocardial infarction.

Related Experiment Videos

  • Reporting of key clinical outcomes including repeat MI and mortality.

    • Main Results:

    • The study included 519 patients undergoing direct angioplasty and stenting for acute myocardial infarction.
    • A low rate of repeat myocardial infarction (MI) was observed at 1%.
    • The overall mortality rate in the non-shock group was 3.7%.

    Conclusions:

    • Direct angioplasty and stenting is a safe and effective treatment strategy for patients presenting with acute myocardial infarction.
    • Stenting significantly reduces the risk of recurrent ischemia, restenosis, and reocclusion compared to traditional PTCA.
    • The ICPS registry data supports the favorable outcomes reported in previous stent trials for acute MI management.